關節設備市場規模、佔有率、成長分析（按產品、應用、最終用戶和地區）- 2025 年至 2032 年產業預測

預計 2023 年全球關節裝置市場價值將達到 29.4 億美元，從 2024 年的 30.9 億美元成長至 2032 年的 46 億美元，預測期內（2025-2032 年）複合年成長率為 5.1%。

受心血管、神經血管和周邊血管疾病發病率上升的推動，全球封堵裝置市場呈現強勁成長動能。閉塞解除、栓塞和支持裝置等關鍵產品對於有效的治療通訊協定至關重要。人口老化和微創手術技術的進步進一步推動了市場擴張。此外，血管內手術的轉變以及對門診手術中心等門診病人環境的偏好日益增加也在推動需求。由於心血管疾病的高發性和主要製造商的存在，北美佔據市場領先地位。另一方面，由於醫療保健基礎設施的改善和患者意識的提高，歐洲和亞太地區正在經歷顯著的成長。預計這一趨勢在不久的將來還將繼續下去。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

關節裝置市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 堵塞清除裝置
  • 氣囊連接裝置
  • 支架回收裝置
  • 線圈回收器
  • 吸痰器及吸痰裝置
• 栓塞裝置
  • 栓塞線圈
  • 液態栓塞劑
  • 腎小管封堵器
• 支援的設備
  • 微導管
  • 導管導引線

關節裝置市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 神經病學
• 心臟病學
• 周圍血管疾病
• 泌尿系統
• 腫瘤學
• 婦科

關節設備市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診斷中心
• 手術中心
• 門診治療中心
• 研究實驗室和學術機構

關節裝置市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Boston Scientific Corporation（United States）
• Medtronic PLC（Ireland）
• Terumo Corporation（Japan）
• Stryker Corporation（United States）
• Penumbra, Inc.（United States）
• Abbott Laboratories（United States）
• Edwards Lifesciences Corporation（United States）
• Johnson & Johnson（United States）
• Merit Medical Systems, Inc.（United States）
• Lepu Medical Technology Co., Ltd.（China）
• Asahi Intecc Co., Ltd.（Japan）
• AngioDynamics, Inc.（United States）
• Cardinal Health, Inc.（United States）
• Avinger, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• CR Bard, Inc.（United States）
• Cook Medical Incorporated（United States）
• Acrostak International Distribution Sarl（Switzerland）

結論和建議

Global Occlusion Devices Market size was valued at USD 2.94 billion in 2023 and is poised to grow from USD 3.09 billion in 2024 to USD 4.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global occlusion devices market is on a robust growth trajectory, driven by the rising incidence of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions. Key products including occlusion removal devices, embolization devices, and support devices are integral to effective treatment protocols. The aging population and advancements in minimally invasive surgical techniques are further propelling market expansion. Moreover, the shift towards endovascular procedures and an increasing preference for outpatient settings, like ambulatory surgical centers, are boosting demand. North America leads the market, thanks to a high prevalence of cardiovascular issues and the presence of major manufacturers. Meanwhile, Europe and Asia-Pacific are experiencing significant growth due to enhanced healthcare infrastructure and rising patient awareness. This trend is expected to persist in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Occlusion Devices Market Segmental Analysis

Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Occlusion Devices Market

The global occlusion devices market is primarily driven by the rising prevalence of cardiovascular and neurovascular diseases, as well as peripheral vascular conditions. The growing incidence of these health issues necessitates effective therapeutic solutions like occlusion devices to restore blood flow and mitigate complications. This demand is further amplified by an aging population and increasing unhealthy lifestyle choices. Additionally, advancements in minimally invasive techniques have transformed occlusion treatment, offering patients non-surgical options that reduce trauma, expedite recovery, and enhance outcomes. The introduction of innovative devices, including occlusion removal and embolization devices, with improved safety and efficacy, is fostering significant market growth.

Restraints in the Global Occlusion Devices Market

The global occlusion devices market faces several significant restraints, primarily due to rigorous regulatory approval processes designed to ensure patient safety and product effectiveness. Securing necessary approvals, such as those from the FDA or obtaining CE marking, is often a lengthy and expensive endeavor. This regulatory landscape presents considerable hurdles, especially for small and medium-sized enterprises looking to enter or enhance their market footprint. Additionally, the high costs associated with manufacturing occlusion devices-encompassing occlusion removal, embolization, and support devices-are another limiting factor. The substantial expenses tied to research, development, and the use of specialized materials drive up prices, restricting market access and adoption, particularly in regions with constrained healthcare budgets and emerging economies where affordability is a critical concern.

Market Trends of the Global Occlusion Devices Market

The Global Occlusion Devices market is witnessing a significant shift towards bioresorbable occlusion devices, driven by their ability to dissolve and be absorbed by the body, thereby eliminating the need for device removal procedures. This burgeoning demand is largely fueled by the advantages these devices offer, including minimized long-term complications and enhanced patient comfort. Manufacturers are increasingly channeling investments into research and development to refine bioresorbable materials, focusing on boosting safety and efficacy. This trend reflects a broader movement toward patient-centric healthcare solutions, highlighting a growing preference for personalized treatment options within the realm of occlusion device interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Occlusion Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Occlusion Removal Devices
  • Balloon Occlusion Devices
  • Stent Retrievers
  • Coil Retrievers
  • Suction & Aspiration Devices
• Embolization Devices
  • Embolic Coils
  • Liquid Embolic Agents
  • Tubal Occlusion Devices
• Support Devices
  • Microcatheters
  • Guidewires

Global Occlusion Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Neurology
• Cardiology
• Peripheral Vascular Diseases
• Urology
• Oncology
• Gynecology

Global Occlusion Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers,
• Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes

Global Occlusion Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acrostak International Distribution Sarl (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations